Physician profile
Sondra Philips
NPI 1407415128
$1,238.52
in general payments reported to CMS, 2019-2025
14 companies · $455 in 2025
The $455 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $145 · 2022: $91.20 · 2023: $247 · 2024: $300 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $244.67 | 2024-2025 | Farxiga, Breztri |
| Abbvie INC. | $244.63 | 2021-2025 | |
| Phathom Pharmaceuticals, INC. | $133.46 | 2024 | Voquezna |
| Novo Nordisk INC | $131.00 | 2022-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $94.73 | 2025 | |
| Lilly USA, LLC | $81.39 | 2025 | Kisunla, Mounjaro, Zepbound |
| Insulet Corporation | $78.26 | 2023-2025 | Omnipod, Omnipod |
| Janssen Pharmaceuticals, INC | $75.71 | 2021 | |
| Pfizer INC. | $45.99 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $32.32 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $25.78 | 2021 | |
| Xeris Pharmaceuticals, INC. | $21.40 | 2022 | |
| Exact Sciences Corporation | $14.84 | 2025 | The Cologuard Plus Collection Kit |
| Alkermes, INC. | $14.34 | 2025 | Aristada, Aristada Initio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sondra Philips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.